107 related articles for article (PubMed ID: 2838842)
1. Bombesin inhibits growth of human pancreatic adenocarcinoma in nude mice.
Alexander RW; Upp JR; Poston GJ; Townsend CM; Singh P; Thompson JC
Pancreas; 1988; 3(3):297-302. PubMed ID: 2838842
[TBL] [Abstract][Full Text] [Related]
2. Effect of somatostatin and tamoxifen on the growth of human pancreatic cancers in nude mice.
Poston GJ; Townsend CM; Rajaraman S; Thompson JC; Singh P
Pancreas; 1990 Mar; 5(2):151-7. PubMed ID: 2156257
[TBL] [Abstract][Full Text] [Related]
3. Bombesin inhibits growth of pancreatic ductal adenocarcinoma (H2T) in nude mice.
Farre A; Ishizuka J; Gomez G; Evers BM; Saydjari R; Koo JY; Townsend CM; Thompson JC
Pancreas; 1994 Sep; 9(5):652-6. PubMed ID: 7809021
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995.
Upp JR; Olson D; Poston GJ; Alexander RW; Townsend CM; Thompson JC
Am J Surg; 1988 Jan; 155(1):29-35. PubMed ID: 2893555
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro.
Qin Y; Ertl T; Cai RZ; Halmos G; Schally AV
Cancer Res; 1994 Feb; 54(4):1035-41. PubMed ID: 8313359
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of a cholecystokinin antagonist, loxiglumide (CR-1505), on the growth of freshly separated and xenografted human pancreatic cancer.
Morimoto H; Nio Y; Tsubono M; Tseng CC; Kawabata K; Masai Y; Hayashi H; Baba N; Manabe T; Hosokawa Y
J Surg Oncol; 1993 May; 53(1):47-53. PubMed ID: 8386784
[TBL] [Abstract][Full Text] [Related]
7. Bombesin stimulates growth of human gastrinoma.
Chung DH; Evers BM; Beauchamp RD; Upp JR; Rajaraman S; Townsend CM; Thompson JC
Surgery; 1992 Dec; 112(6):1059-65. PubMed ID: 1455308
[TBL] [Abstract][Full Text] [Related]
8. Effects of bombesin on growth of human small cell lung carcinoma in vivo.
Alexander RW; Upp JR; Poston GJ; Gupta V; Townsend CM; Thompson JC
Cancer Res; 1988 Mar; 48(6):1439-41. PubMed ID: 2830965
[TBL] [Abstract][Full Text] [Related]
9. Specific binding of cholecystokinin, estradiol and somatostatin to human pancreatic cancer xenografts.
Singh P; Townsend CM; Poston GJ; Reubi JC
J Steroid Biochem Mol Biol; 1991 Nov; 39(5A):759-67. PubMed ID: 1683561
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice.
Yano T; Pinski J; Szepeshazi K; Halmos G; Radulovic S; Groot K; Schally AV
Cancer; 1994 Feb; 73(4):1229-38. PubMed ID: 8313327
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.
Szepeshazi K; Schally AV; Cai RZ; Radulovic S; Milovanovic S; Szoke B
Cancer Res; 1991 Nov; 51(21):5980-6. PubMed ID: 1682039
[TBL] [Abstract][Full Text] [Related]
12. Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP.
Qin Y; Ertl T; Cai RZ; Horvàth JE; Groot K; Schally AV
Int J Cancer; 1995 Oct; 63(2):257-62. PubMed ID: 7591214
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.
Pinski J; Halmos G; Yano T; Szepeshazi K; Qin Y; Ertl T; Schally AV
Int J Cancer; 1994 May; 57(4):574-80. PubMed ID: 7910153
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of new anticancer agents against human pancreatic carcinomas in nude mice.
Sternberg CN; Sordillo PP; Cheng E; Chuang YJ; Niedzwiecki D
Am J Clin Oncol; 1987 Jun; 10(3):219-21. PubMed ID: 2884864
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095.
Miyazaki M; Lamharzi N; Schally AV; Halmos G; Szepeshazi K; Groot K; Cai RZ
Eur J Cancer; 1998 Apr; 34(5):710-7. PubMed ID: 9713279
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of the trophic actions of bombesin on the pancreas.
Upp JR; Poston GJ; MacLellan DG; Townsend CM; Barranco SC; Thompson JC
Pancreas; 1988; 3(2):193-8. PubMed ID: 2453876
[TBL] [Abstract][Full Text] [Related]
17. [Effects of anti-tumor drugs and gastrointestinal hormones on the growth of pancreatic duct cell adenocarcinoma in homologous transplanted animal models].
Ohyama K
Hokkaido Igaku Zasshi; 1985 Mar; 60(2):206-16. PubMed ID: 2987090
[TBL] [Abstract][Full Text] [Related]
18. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II.
Kahán Z; Sun B; Schally AV; Arencibia JM; Cai RZ; Groot K; Halmos G
Cancer; 2000 Mar; 88(6):1384-92. PubMed ID: 10717621
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095).
Radulovic S; Miller G; Schally AV
Cancer Res; 1991 Nov; 51(21):6006-9. PubMed ID: 1682040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
